Adi Sapir (Author)
Oliver, Amalya L. (Author)
This paper examines how the Weizmann Institute of Science has been telling the story of the successful commercialization of a scientific invention, through its corporate communication channels, from the early 1970s to today. The paper aims to shed light on the transformation processes by which intellectual-property-based commercialization activities have become widely institutionalized in universities all over the world, and on the complexities, ambiguities and tensions surrounding this transition. We look at the story of the scientific invention of Copolymer-1 at the Weizmann Institute of Science and its licensing to Teva Pharmaceutical Industries, which subsequently developed the highly successful drug Copaxone for the treatment of multiple sclerosis. We argue that, in its tellings and retellings of the story of Copolymer-1, the Weizmann Institute has created narratives that serve to legitimize the institution of academic patenting in Israel.
...More
Article
Biddle, Justin B.;
(2014)
Can Patents Prohibit Research? On the Social Epistemology of Patenting and Licensing in Science
(/isis/citation/CBB001320767/)
Article
Baldini, Nicola;
Fini, Riccardo;
Grimaldi, Rosa;
Sobrero, Maurizio;
(2014)
Organisational Change and the Institutionalisation of University Patenting Activity in Italy
(/isis/citation/CBB001420874/)
Article
Andrew Kretz;
(2013)
Inventions for Industry. Canadian Patents and Development Limited and the Commercialization of University Research in Canada
(/isis/citation/CBB655467580/)
Article
Hallacher, Paul M.;
(2008)
Notes from the Field: NASA and government technology commercialization activities
(/isis/citation/CBB680758362/)
Book
B. Zorina Khan;
(2020)
Inventing ideas : patents, prizes, and the knowledge economy
(/isis/citation/CBB655098948/)
Article
Doogab Yi;
(2022)
Correcting Life through the Marketplace? Genome Editing and the Commercialization of Academic Research in South Korea
(/isis/citation/CBB498505166/)
Book
Hans Radder;
(2019)
From Commodification to the Common Good: Reconstructing Science, Technology, and Society
(/isis/citation/CBB983107822/)
Chapter
Hayden, Cori;
(2011)
No Patent, No Generic: Pharmaceutical Access and the Politics of the Copy
(/isis/citation/CBB001221561/)
Article
McMillan, Vernotto C.;
(2008)
Technology Transition: A Model for Infusion and Commercialization
(/isis/citation/CBB275121586/)
Article
Mario Biagioli;
Alain Pottage;
(2021)
Patenting Personalized Medicine: Molecules, Information, and the Body
(/isis/citation/CBB302669888/)
Book
Katerina Sideri;
(2016)
Bioproperty, Biomedicine and Deliberative Governance: Patents as Discourse on Life
(/isis/citation/CBB016823973/)
Book
Con Díaz Gerardo;
(2019)
Software Rights: How Patent Law Transformed Software Development in America
(/isis/citation/CBB992270814/)
Chapter
Samuelson, Pamela;
(2011)
The Strange Odyssey of Software Interfaces as Intellectual Property
(/isis/citation/CBB001221563/)
Chapter
Simone Turchetti;
(2009)
Il brevetto, la bomba atomica e l'FBI : storia del brevetto Fermi sul metodo per la produzione di sostanze radioattive artificiali, 1934-1953
(/isis/citation/CBB699442517/)
Article
Stevens, Ashley J.;
(2003)
Notes from the Field: Commercialization of university research
(/isis/citation/CBB267242609/)
Article
Sobol, Marion Gross;
Newell, M. Karen;
(2003)
Barriers to and Measurements of the Diffusion of Technology from the University to Industry
(/isis/citation/CBB069883803/)
Article
Rath, Amitav;
(2006)
Notes from the Field: Technology Spinoffs in Taiwan
(/isis/citation/CBB733347514/)
Thesis
Gerardo Con Diaz;
(2016)
Intangible Inventions: A History of Software Patenting in the United States, 1945-1985
(/isis/citation/CBB374973840/)
Article
Kraemer, Sylvia Katharine;
(2001)
Federal Intellectual Property Policy and the History of Technology: The Case of NASA Patents
(/isis/citation/CBB000101814/)
Book
Mowery, David C.;
(2004)
Ivory Tower and Industrial Innovation: University-Industry Technology before and after the Bayh-Dole Act in the United States
(/isis/citation/CBB000470132/)
Be the first to comment!